ISSN 1662-4009 (online)

ey0018.2-12 | Neonatal diabetes mellitus | ESPEYB18

2.12. Neonatal diabetes mutations disrupt a chromatin pioneering function that activates the human insulin gene

I Akerman , MA Maestro , E De Franco , V Grau , S Flanagan , J Garcia-Hurtado , G Mittler , P Ravassard , L Piemonti , S Ellard , AT Hattersley , J Ferrer

Cell Rep. 2021 Apr 13;35(2):108981. doi: 10.1016/j.celrep.2021.108981. PMID: 33852861.Mutations in the promotor region of the insulin gene are associated with a subtype of neonatal diabetes mellitus (NDM). These mutations lead to abnormal transcription of the insulin gene and do so by deleting the C1 and E1 cis regulatory elements, or three different single base-pair substitutions in ...

ey0018.1-11 | Genetics | ESPEYB18

1.11. Pituitary stalk interruption syndrome broadens the clinical spectrum of the TTC26 ciliopathy

O David , M Eskin-Schwartz , G Ling , V Dolgin , E Kristal , E Benkowitz , L Osyntsov , L Gradstein , OS Birk , N Loewenthal , B Yerushalmi

Clin Genet. 2020 Sep;98(3):303-307. doi: 10.1111/cge.13805. PMID: 32617964.In this case series, David et al. describe clinical features of 4 patients in 2 unrelated consanguineous families with TTC26 ciliopathy due to a homozygous c.695A>G p.Asn232Ser mutation. Three of the patients had MRI findings consistent with pituitary stalk interruption syndrome (PSIS), a congenital anomaly o...

ey0018.8-5 | Important for Clinical Practice | ESPEYB18

8.5. Improved urinary cortisol metabolome in addison disease: A prospective trial of dual-release hydrocortisone

S Espiard , J McQueen , M Sherlock , O Ragnarsson , R Bergthorsdottir , P Burman , P Dahlqvist , B Ekman , BE Engstrom , S Skrtic , J Wahlberg , PM Stewart , G Johannsson

J Clin Endocrinol Metab 2021; 106(3):814–825.https://pubmed.ncbi.nlm.nih.gov/33236103/Here, the authors performed a randomized, 12-week, crossover study in order to assess cortisol metabolism during dual-release hydrocortisone (DR-HC) and conventional hydrocortisone (TID-HC) therapy in patients with primary adrenal insufficiency (n=50). Healthy controls (n=124) were i...

ey0019.8-7 | Important for Clinical Practice | ESPEYB19

8.7. Low adrenomedullary function predicts acute illness in infants with classical Congenital Adrenal Hyperplasia

J Weber , VK Tanawattanacharoen , A Seagroves , MC Liang , CM Koppin , HM Ross , TASS Bachega , ME Geffner , M Serrano-Gonzalez , G Bhullar , MS Kim

J Clin Endocrinol Metab. 2022; 107(1): e264–e271. PMID: 34397083https://pubmed.ncbi.nlm.nih.gov/34397083/ Brief Summary: This prospective cohort study determined plasma epinephrine concentrations in infants with classic CAH, and showed that the lower epinephrine reseve is associated with increased risk of illness.Children and adolescents with classical Congenital ...

ey0020.2-3 | Important for Clinical Practice | ESPEYB20

2.3. Timing of puberty, pubertal growth, and adult height in short children born small for gestational age treated with growth hormone

EN Upners , LL Raket , JH Petersen , A Thankamony , E Roche , G Shaikh , J Kirk , H Hoey , SA Ivarsson , O Soder , A Juul , RB Jensen

Brief summary: In this study the authors reported the adult height and timing of puberty of a cohort of Danish children born small for gestational age (SGA) and treated with rhGH in comparison with national growth standards. rhGH treatment significantly increased height SDS in adulthood as compared to the height SDS at treatment start. Age at peak height velocity did not differ compared with the reference cohort, although peak height velocity was reduced in SGA subjects. SGA b...

ey0019.6-8 | Basic and Genetic Research of DSD | ESPEYB19

6.8. Targeting the non-coding genome for the diagnosis of disorders of sex development

G Atlas , R Sreenivasan , A Sinclair

Sex Dev. 2021;15(5-6):392-410. PMID: 34634785, doi: 10.1159/000519238. Brief Summary: This review summarizes how non-coding genomic variants are identified and validated, and why non-coding defects found in DSD patients have to be considered when investigating the genetic etiology of DSD.Accurate genetic diagnosis of 46,XY DSD patients remains crucial for early treatment and ...

ey0017.13-9 | Endocrinology | ESPEYB17

13.9. People are taller in countries with better environmental conditions

A German , G Mesch , Z Hochberg

To read the full abstract: Front. Endocrinol. 2020; 11:106. doi: 10.3389/fendo.2020.00106• The authors assessed the relationship between markers of a stressful environment and final height in adult men and women in 71 countries (including 31 countries that are members of the Organisation for Economic Co-operation and Development [OECD]).• They found that the more stressful the e...

ey0020.14-3 | Section | ESPEYB20

14.3. People are taller in countries with better environmental conditions

A German , G Mesch , Z Hochberg

Brief summary: The authors assessed the relationship between markers of a stressful environment and final height in adult men and women in 71 countries (including 31 countries that are members of the Organisation for Economic Co-operation and Development [OECD]). They found that the more stressful the environment, the shorter the adult height. By order of decreasing importance, the relationship between markers of a stressful environment and height were income inequality > ...

ey0018.7-6 | Clinical Guidance | ESPEYB18

7.6. GnRH stimulation testing and serum inhibin B in males: insufficient specificity for discriminating between congenital hypogonadotropic hypogonadism from constitutional delay of growth and puberty

H Mosbah , C Bouvattier , L Maione , S Trabado , G De Filippo , A Cartes , A Donzeau , P Chanson , S Brailly-Tabard , AA Dwyer , R Coutant , J Young

Hum Reprod. 2020 Oct 1;35(10):2312–2322. 10.1093/humrep/deaa185. PMID: 32862222. https://academic.oup.com/humrep/article/35/10/2312/5899242In brief: This study shows that both the GnRH stimulation test and serum inhibin B have insufficient specificity to discriminate congenital hypogonadotropic hypogonadism (CHH) from c...

ey0019.1-10 | Clinical Papers | ESPEYB19

1.10. Genetics, clinical features and outcomes of non-syndromic pituitary gigantism: experience of a single center from Sao Paulo, Brazil

EB Trarbach , G Trivellin , IPP Grande , FHG Duarte , AAL Jorge , FBP do Nascimento , HM Garmes , M Nery , BB Mendonca , CA Stratakis , MD Bronstein , RS Jallad

Pituitary. 2021;24(2):252-261. doi: 10.1007/s11102-020-01105-4. PMID: 33156432.Brief Summary: Pituitary gigantism is a rare disease, which can be syndromic, as in McCune-Albright syndrome, Carney complex, MEN1 and MEN4, and the newly described “three P association” (paraganglioma, pheochromocytoma and pituitary adenoma) (1), or non-syndromic caused by mutations ...